Pay in 4 interest-free payments of $62.50 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
4-tetrahydropyrimidin-4-one
(-)-(S)-Equol might have applications as an anti-type 2 diabetic agent
Kennedy RT
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program
CV-6209 roxypyridine-2-carboxylate 4-tetrahydropyrimidin-4-oneCV 6209 is a potent antagonist of the platelet activating factor (PAF) receptor, with IC50 values of 75 and 170 nM, respectively. CV 6209 has little action on platelet aggregation induced by arachidonic acid, ADP, or collagen. CV 6209 is used to study the role of PAF receptor signaling in vitro and in vivo. Product information CAS Number: 100488 87 7 Molecular Weight: 642. 31 Formula: C34H60ClN3O6 Synonym: [2 methoxy 3 (octadecylcarbamoyloxy)propyl] N
US$ 125.00
US$ 75.20
US$ 119.00
US$ 619.40
US$ 325.00
US$ 107.15
US$ 42.00
US$ 163.50